Taurine Supplementation Inhibits the Expression of Atrogin-1 and MURF-1, Protein Degradation Marker Genes, in Skeletal Muscle of C26-Induced Cachexia Mouse Model.

Doss, Hari Madhuri; Kim, Jung Yeon; Kim, Kyoung Soo

Doss, Hari Madhuri; Kim, Jung Yeon; Kim, Kyoung Soo.

Afiliación

Doss HM; Department of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul, South Korea.
Kim JY; Department of Pathology, Inje University Sanggye Paik Hospital, Seoul, South Korea.
Kim KS; Department of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul, South Korea. kimks@khu.ac.kr.

Adv Exp Med Biol ; 1370: 129-136, 2022.

Article en En | MEDLINE | ID: mdl-35882788

Asunto(s)

Caquexia; Neoplasias; Animales; Caquexia/tratamiento farmacológico; Caquexia/genética; Suplementos Dietéticos; Modelos Animales de Enfermedad; Ratones; Músculo Esquelético/metabolismo; Atrofia Muscular/tratamiento farmacológico; Atrofia Muscular/genética; Neoplasias/patología; Proteolisis; Taurina/metabolismo; Taurina/farmacología; Taurina/uso terapéutico

Palabras clave

Atrogin-1; MuRF-1; Sarcopenia; Skeletal muscle

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Caquexia / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Adv Exp Med Biol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google